Athenex
Benson Tsang brings over 30 years of financial and general management experience to Athenex. He previously held the role of Chief Financial Officer of WuXi Pharmatech Inc. where he was instrumental in the company’s successful IPO in 2007, and served as an independent director of Shangpharma Corp. Benson also held senior positions at ATA Inc, PCCW Ltd., Imation Corp., Coopers & Lybrand and Deloitte. He is a member of the Chartered Professional Accountants of Canada and the Hong Kong Institute of Certified Public Accountants. Benson holds a Bachelor of Commerce degree and an MBA from McMaster University in Ontario, Canada.
Benson is currently the Executive Director of Puritek Canada Inc.
This person is not in the org chart
This person is not in any offices
Athenex
Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies.